Abstract
A series of 2-aryl-naphtho[1,2-d]oxazole derivatives have been synthesized and evaluated for PTP-1B inhibitory activity. The compounds have been screened in vivo for antidiabetic activity under sucrose loaded model (SLM), sucrose-challenged streptozotocin-induced diabetic rat model (STZ-S) and db/db mice model. Compounds 8 and 12 have shown promising PTP-1B inhibitory activity, significant antidiabetic activity, moderate lipid and triglyceride lowering activity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Diabetes Mellitus, Experimental / drug therapy*
-
Enzyme Inhibitors
-
Hypoglycemic Agents / chemistry*
-
Hypoglycemic Agents / pharmacology
-
Lipids / blood
-
Mice
-
Oxazoles / chemistry*
-
Oxazoles / pharmacology
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
-
Rats
-
Structure-Activity Relationship
-
Triglycerides / blood
Substances
-
Enzyme Inhibitors
-
Hypoglycemic Agents
-
Lipids
-
Oxazoles
-
Triglycerides
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1
-
Ptpn1 protein, mouse